Raimund Mannhold and Gerard Leclerc Pages 961 - 969 ( 9 )
This review discusses structural aspects of second-generation KATP channel openers (KCOs), which exhibit improved tissue-selectivity. Their therapeutic profile is debated with main focus on cardiac ischemia, asthma, and urinary incontinence.
katp channel openers (kcos), benzopyrans, cyclobutenediones, dihydropyridine related structures, tertiary carbinols, structure-activity relationships, therapeutic potential, myocardial ischemia, asthma, urinary incontinence
Department of Laser Medicine, Molecular Drug Research Group, Heinrich-Heine-Universitat, Universitatsstraße 1, 40225 Dusseldorf, Germany.